Clinical Utility of Modified Asian FINDRISC and Random Capillary Blood Glucose for the Detection of Dysglycemia in the Adult Population
https://doi.org/10.15605/jafes.041.S1
- Author:
Jie En Tan
1
;
Nor Shaffinaz Yusoff Azmi Merican
2
;
Florence Hui Sieng Tan
1
Author Information
1. Sarawak General Hospital
2. Sultanah Bahiyah Hospital
- Publication Type:Journal Article
- From:
Journal of the ASEAN Federation of Endocrine Societies
2026;41(S1):34-
- CountryPhilippines
- Language:English
-
Abstract:
Introduction:Type 2 diabetes mellitus is a major healthcare problem
worldwide, yet high percentage of patients are undiagnosed. There is a dire need for effective screening strategies.
We examine the use of modified Asian FINDRISC
(M-FINDRISC) and POCT random capillary blood glucose
(rCBG) for the detection of dysglycemia
Methodology:This cross-sectional, observational study included 151
adults aged ≥30 years without a prior history of diabetes
in healthcare and community settings. Hemoglobin A1c
of ≥6.3% was used for the diagnosis of diabetes, and 5.7–
6.2% for prediabetes. Areas under the receiver operating
curve (ROC-AUC) for M-FINDRISC were analyzed.
The sensitivity and specificity of the combined use of
M-FINDRISC and rCBG for the detection of dysglycemia
were evaluated.
Results:The mean age of the participants was 44.6 ± 11.0 years.
They had high body mass index (27.8 ± 4.9 kg/m²). Most
were sedentary (only 25.2% reported physical activities
of ≥30 min/day). A total of 52.3% had first-degree
relatives with diabetes, but less than 12% were taking
antihypertensive medication. Out of 151 participants, 3.3%
(n = 5) were diagnosed with diabetes mellitus and 37.7%
(n = 57) with prediabetes, giving an overall prevalence of
41.1% for dysglycemia. The mean age of participants with
dysglycemia was significantly older (47.9 vs. 42.3 years,
p-value 0.002). Other parameters were not statistically
different for the two groups. Mean M-FINDRISC score was
9.7 ± 3.9 in the normal and 10.8 ± 4.0 in the dysglycemic
group, while rCBG was 6.4 ± 1.1 mmol/L and 7.1 ± 3.1
mmol/L, respectively. ROC-AUC of M-FINDRISC for
dysglycemia was 0.561. A combined screening strategy
(M-FINDRISC score ≥7.5 and CBG ≥7.8 mmol/L) yielded
high specificity (89.9%) but low sensitivity (17.7%) for
dysglycemia.
Conclusion:While the combined screening strategy utilizing
M-FINDRISC and POCT random CBG improves specificity, M-FINDRISC showed limited predictive value for
dysglycemia in this specific cohort, making it a less ideal
tool for screening.
- Full text:2026072816484695036EP_A029.pdf
